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Abstract
Background:  Resource allocation models have not had a substantial impact on HIV/AIDS
resource allocation decisions in spite of the important, additional insights they may provide. In this
paper, we highlight six difficulties often encountered in attempts to implement such models in
policy settings; these are: model complexity, data requirements, multiple stakeholders, funding
issues, and political and ethical considerations. We then make recommendations as to how each of
these difficulties may be overcome.
Results: To ensure that models can inform the actual decision, modellers should understand the
environment in which decision-makers operate, including full knowledge of the stakeholders' key
issues and requirements. HIV/AIDS resource allocation model formulations should be
contextualized and sensitive to societal concerns and decision-makers' realities. Modellers should
provide the required education and training materials in order for decision-makers to be
reasonably well versed in understanding the capabilities, power and limitations of the model.
Conclusion:  This paper addresses the issue of knowledge translation from the established
resource allocation modelling expertise in the academic realm to that of policymaking.
Background
Resource allocation models can provide valuable guid-
ance to the rational allocation of funds. Improving the use
of funds by targeting areas of greatest return may lead to
better and/or greater health outcomes. Although there is
growing pressure to use formal modelling techniques in
healthcare [1], their impact on healthcare resource alloca-
tion has been rather limited [2-4]. In addition, there is evi-
dence that actual spending decisions tend to deviate from
what formal models might suggest [5]. The decision-mak-
ing process for HIV/AIDS resource allocation is a combi-
nation of several components, including historical
spending patterns, influential players such as advocacy
group or donors, priority setting assessments and formal
models. Thus, resource allocation models are but one
component of a broader allocation process. We argue that
healthcare modellers can benefit from a comprehensive
understanding of all components of a resource allocation
process in order to improve model acceptance among
decision-makers and the contribution of models to the
overall process.
This article explores several factors that tend to prevent the
application of formal resource allocation models and pro-
vides recommendations as to how these barriers to imple-
mentation can be overcome.
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Overview of HIV/AIDS resource allocation 
models
Resource allocation is defined as the distribution of
resources among programs, populations or regions that
are competing for the same funds [6]. Several types of
approaches have been employed in creating resource allo-
cation models for HIV/AIDS interventions funds, and
methodologies have evolved over time. Initial models
employed basic methodology such as the allocation of
funds proportional to the number of HIV and/or AIDS
cases in target groups [7,8] and allocation choices deter-
mined by ranking cost-effectiveness league tables [5,9,10].
From this starting point, there have been continual refine-
ments in modelling techniques. The first of these refine-
ments focused on the underlying epidemic with complex
dynamic models constructed to reflect the impact of
resource allocation choices on the spread of disease [11].
More recent models implement simulation optimization
techniques or non-linear programming to determine opti-
mal allocation for epidemiological models of varying
degrees of sophistication [12]. Another means of refine-
ment involved direct modelling of current funding strate-
gies within the resource allocation model [13,14]. Others
have focussed on determining the optimal location of
facilities for maximizing the accessibility of antiretrovirals
[15-17].
The emphasis on techniques may reflect several aims
within the research community. There is a requirement for
greater accuracy in the epidemic projections used as a
basis for resource allocation. Scientific accuracy can help
withdraw HIV/AIDS resource allocation issues from the
political arena and minimize subjectivity in the allocation
process. Politics and value judgments tend to be at odds
with rational comprehensive decision-making processes
for allocating of resources [18-20]. However, highly com-
plex, difficult to understand and use, formal models have
led to difficulties in the actual implementation of these
models in real-world decision-making.
Discussion
In this section we discuss the main barriers to the adop-
tion of HIV/AIDS resource allocation models and provide
recommendations for overcoming these barriers.
Model complexity
Barriers to the use of formal models in healthcare include
decision-makers' lack of appreciation and understanding
of models and their conclusions [21]. Decision-makers
should understand the conceptual foundation of a model
and its calculations to gain confidence in its results and
implement its recommendations, especially when these
seem counterintuitive.
Relatively few resource allocation publications appear in
medical or public policy journals compared to the body of
resource allocation literature published in quantitative
journals. This difference underscores the lack of knowl-
edge transfer from healthcare modelling to decision-mak-
ing. Published examples documenting the lack of model
usage are difficult to find. We identified only one com-
mentary by Kaplan on an HIV resource allocation model
designed for community planning groups [22]. The
model was not implemented because the intended users
did not comprehend or accept it or its results [22].
Some suggest that modellers tend to focus on the sophis-
tication of the mathematical formulation of models for
the control of sexually transmitted diseases rather than on
practical relevance [23]. Given the common lack of math-
ematical knowledge among decision-makers, sophisti-
cated models tend to widen the gap between modellers
and the decision-makers originally intended to use the
models [23]. Stover suggests that mathematical models of
HIV/AIDS have had little influence on policies in develop-
ing countries because decision-makers believe that mod-
els are incomprehensible and do not yield realistic
recommendations [24]. This latter point is exacerbated by
the fact that most models do not consider the potential
synergism or antagonism resulting from the interaction of
several types of interventions typically conducted simulta-
neously within a single community. While models could
consider these interactions, there is a lack of reliable data
to support them. Finding means to address these issues to
the satisfaction of the policymaker and the modeller is
important for model usage.
Recommendations
Resource allocation models should be considered a proc-
ess to be undertaken by all parties involved, rather than a
product to be delivered by the modeller. Modellers need
to fully understand the requirements of their potential
end users as well as the decision-making environment in
which these users function. Model development should
proceed from simple to increasingly complex, with con-
sultations between modellers and end users to determine
the appropriate level of complexity of each aspect of the
model. Modellers should arrange for education and train-
ing materials in order for users to be reasonably well
versed in the features, power and limitations of the model.
Documentation should be in language that is clear to the
intended users; this might require different documenta-
tion for different users of the same model. Graphical rep-
resentations tend to avoid the need for extensive
mathematical notation. End users should provide the
modeller with necessary information for model develop-
ment in a timely manner and be open to question their
own views and assumptions of the process to be mod-
elled. When there are multiple groups of potential users,BMC Public Health 2009, 9(Suppl 1):S8 http://www.biomedcentral.com/1471-2458/9/S1/S8
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discussion on the model formulation and structuring is
pivotal to developing consensus. To expedite and ease
these discussions, each group of intended users should
designate one individual as a "translator" or "spokesper-
son" between the modeller and the group. Also, when
there is a team of modellers, a spokesperson should be
designated and selected based the ability to communicate
complex mathematical methods in a logical and accessi-
ble manner. Frequent discussions with the intended users
will ensure that the model is relevant and comprehensi-
ble.
Data requirements
Context-specific data requirements for models can be
onerous. The Institute of Medicine cites a lack of resource
allocation frameworks that rely on existing data [25].
Many HIV/AIDS resource allocation models require infor-
mation that is not available or collected by governmental
or research agencies, such as behavioural data of risk
groups within a community. In the absence of data,
assumptions must be made. However, decision-makers
are wary of models lacking requisite supporting data since
this lack could lead to unfortunate decisions. For example,
should behavioural patterns observed in the general pop-
ulation be applied to a high risk group due to a lack of
available data, then interventions in that group may not
seem cost-effective even if, in reality, they are [26]. Deci-
sion-makers' uncertainty about data estimates and
assumptions can lead to a wholesale rejection of decision-
support models.
In addition to information about epidemic propagation,
HIV resource allocation models often rely on intervention
cost and effectiveness data which is difficult to obtain. The
CDC published the Compendium of HIV Prevention
Interventions which contains a list of interventions
deemed effective but it does not provide any cost esti-
mates [27]. Some cost data are available in the published
literature, but they tend to be specific to the community in
which the intervention was implemented and cannot eas-
ily be transposed to a different context. Intervention pro-
gram costs and outcomes are affected by local
considerations such as transportation availability,
amount of public healthcare delivery, community mobili-
zation and socio-economic status. Holtgrave states that
when "cost-effectiveness information does not exist for a
particular population, the real potential exists for that
population to be put at a disadvantage in the resource
allocation process." (p.184)[28]. In 1993, Birch and Gafni
stated that some assumptions used in cost-effectiveness
analysis are "worlds apart from the problem context fac-
ing decision-makers in the healthcare field" [29]; in a sub-
sequent paper in 2006 they reiterate that cost-effectiveness
analyses are often misused in resource allocation [30].
Recommendations
Modellers should understand data availability a priori and
develop tools that function with the available data. For
example, if program cost or outcome data are not availa-
ble, then resource allocation approaches such as preva-
lence- or incidence-based equity models that do not rely
on these data should be considered. If critical data gaps
are identified, decision-makers may be called upon to col-
lect some of the necessary data either through secondary
sources or by conducting their own surveys. However, this
requires careful balancing of the improvement in resource
allocation that may be attainable with better data and the
amount of time and resources that must be expended to
collect this data. Modellers and policymakers should
update model inputs and regenerate results as more accu-
rate and recent data become available.
Sensitivity analyses are arguably the most powerful and
most underused tools that a modeller has to address these
issues. Sensitivity analysis explores the extent to which
changes in input data affect the model outputs by system-
atically varying data values and model assumptions. Their
use is critical since they can determine whether it is neces-
sary and effective to gather more information. If the rec-
ommendations resulting from the model do not change
over the expected range of values, then decision-makers
can feel more certain of the resource allocations recom-
mended by the models. Sensitivity analyses should not be
presented as an afterthought in the model development
process, but rather explained and touted as an integral
part of the decision-making process. Repeated use of sen-
sitivity analyses to inform decisions about increasing
model complexity can save time and money in the model-
development process.
Multiple stakeholders
In any decision process, multiple stakeholders can affect a
model's development and its acceptability. Resource allo-
cation models may encounter barriers to use when they
optimize the expected outcome from the perspective of
one decision-making body [31]. Different stakeholders
take part in the decision-making process for HIV/AIDS
resource allocation, each with their own objectives, con-
straints and realities; they include donors, lobby groups,
community-based organizations and national, state or
local governments. Eden and Ackerman define a matrix of
the amount of power and interest different stakeholders
have on the decision problem [32]. There are the "Sub-
jects" - those with high interest in the decision but little
power to affect the decision, the "Players" - those with
both high interest and high power to affect the decision,
and the "Context Setters" - those with high power to affect
the decision but with relatively little direct interest in the
decision itself. Players may regard models with suspicion
when they are not consulted in the model building proc-BMC Public Health 2009, 9(Suppl 1):S8 http://www.biomedcentral.com/1471-2458/9/S1/S8
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ess. Subjects can band together to gain political clout as a
Player, as seen in the rise of HIV/AIDS advocacy groups.
They may reject results that appear to be putting their
interests at a disadvantage. Players must interact with
Context Setters who frequently have to make the final
decisions. Belton and Stewart remark upon similar results
seen in other arenas [33].
There is also debate on how health benefits and risks are
assessed within the resource allocation models - by the
affected individuals, by representatives, by experts. Qual-
ity of life assessments vary widely between patients, phy-
sicians and the general public [34-38]. Therefore, the
point of view of the assessor of the benefits can dramati-
cally affect cost-effectiveness analyses. In addition, it is not
clear whether or not all patients should be viewed as a
homogenous group [34]. Treatment costs of HIV/AIDS
and quality-adjusted life years saved will vary by socio-
economic characteristics; there is debate as to whether or
not these should be racially specific or reflective of the
general population [28,39]. Michaelis notes that the deci-
sion to commit resources to AIDS started very slowly
"because the primary victims were socially marginalized
or economically disadvantaged" (p. 400) [40].
Recommendation
It is important to understand stakeholders' needs and
influences, and engage them early in the modelling proc-
ess to increase their willingness to cooperate [41]. The
cooperation of stakeholders is especially important since
maximizing the health benefits of society are frequently
not the same as maximizing the health benefits of the
individual [35,42,43]. Exploring and potentially incorpo-
rating some of the alternate means of achieving distribu-
tive justice is critical for model acceptability, since it is
perceived as an important value representing fairness and
equity [35,44,45].
When multiple players influence decision-making,
resource allocation models are meant to help structure the
problem and promote conflict resolution in a constructive
way [31]. One of the powers of mathematical models is
that all assumptions have to be made explicit before the
model can be implemented and analyzed. The modeller
has a key role of pointing out potentially differing
assumptions and/or goals of all groups involved.
In addition, for models to be accepted by multiple stake-
holders, the variables that serve as input to the model - for
example, treatment access, life years saved, quality adjust-
ments and costs - need to be discussed, documented and
made transparent for review. Again, sensitivity analysis is
key tool to exploring how different values or relative
weights of these inputs influence the outcome of the
model.
Political considerations
While modellers may distance themselves from political
considerations so as to avoid bias in their research,
resource allocation decisions are inevitably influenced by
the politics in the budget appropriations environment.
HIV/AIDS is particularly prone to political debate in part
due to the sexual nature of the disease, involvement of
injection drug use, and the high cost of care and treat-
ment.
In South Africa, the response to the HIV/AIDS has been
riddled with political hurdles. President Thabo Mbeki's
dissident views on HIV/AIDS have been widely reported
[46-49]. Parts of the political leadership in South Africa
have cast doubt on the causal link between HIV and AIDS,
and the efficacy and affordability of antiretroviral treat-
ment [50]. The Treatment Action Campaign (TAC), an
advocacy group, was launched to advance the provision
antiretroviral treatment for people with AIDS. In August
2003, motivated by the TAC, the government consented
to a plan that aimed to have 53,000 people on treatment
by March 2004 [51]. In June 2005, while below this target,
health minister, Dr. Tshabalala-Msimang said she refused
to be "pressured" into increasing the antiretroviral roll-
out to meet a target set by a group of international bodies
without consulting South Africa on its feasibility. She also
reiterated her praise of garlic and lemon: "not only do
they give you a beautiful face and skin but they also pro-
tect you from disease" [52]. Leadership stance, political
power, advocacy groups and the judicial system have
largely influenced South Africa's allocation of HIV/AIDS
funds.
Another example of the overriding impact of political
considerations can be found in the US: an appropriations
bill prohibiting the District of Columbia from using local
tax dollars to operate needle exchange programs was in
effect. The District has some of the highest HIV/AIDS rates
in the country, with one third of its new HIV/AIDS cases
annually attributed to injection drug use. Needle
exchange programs are demonstrably effective in prevent-
ing HIV transmission, cost-effective [53], and do not gen-
erate unsafe disposal of needles [54]. When included in
resource allocation models, needle exchange programs are
some of the first that the models will recommend [55].
Washington DC was the only city prohibited from using
local tax dollars to provide clean needles to IV drug users
until the ban in was lifted in 2007 [56].
Recommendations
Resource allocation decisions should not be devoid of
their socio-political environment [57]. It is difficult, even
impossible to use the results of a rational model to guide
allocation policies without consideration of the political
context [47]. Though formal approaches to resource allo-BMC Public Health 2009, 9(Suppl 1):S8 http://www.biomedcentral.com/1471-2458/9/S1/S8
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cation models cannot alter this level of political power
struggle, they can inform the process. Modellers must
understand the political context and craft flexible models
that allow for restrictions on portions of funds or other
political constraints. Flexible models allow decision-mak-
ers to determine the best course of action within the polit-
ically constrained process as well as the best course if the
political realities can be influenced and changed [20]. To
illustrate the expected impact, the existing allocation of
resources should be presented against the alternative allo-
cations suggested by the model. By highlighting the most
restrictive constraints, models may guide both the effort
and the magnitude of the effort to lobby for change.
Ethics and human rights
Social and ethical considerations include culture, religion,
human rights, societal inter-relationships, and commu-
nity advocacy; all of which are difficult to quantify. An
example of the impact of these considerations can be seen
in the debate on funding treatment versus prevention.
Marseille et al. suggest that prevention be favoured in
order to minimize the number of deaths from HIV/AIDS
in sub-Saharan Africa [58]. Based on a meta-analysis of
the cost-effectiveness of HIV/AIDS programs in Africa,
Creese et al. also argue for prevention interventions [59].
Some disapproved of these economic studies on the basis
that funding decisions should include the right to
improved health for those already infected and that soci-
ety has an ethical duty to treat those who are sick [60-62].
The latter point invokes the rule of rescue which states that
denying treatment to an identified suffering person facing
death is considered morally repugnant by most, while
denying prevention to future sufferers who are a faceless
statistical abstraction is more palatable [63].
The human rights versus public health dichotomy is well
captured in the provocative example of Cuba where test-
ing and contact tracing was compulsory, and from 1985-
1994, diagnosed patients were isolated to a sanatorium
for the HIV/AIDS infected [64,65]. In 2005, it is estimated
that 4800 people in Cuba were living with HIV/AIDS rep-
resenting a prevalence of less than 0.1%, while the average
prevalence for the Caribbean is 1.6% making it the second
most-affected region in the world after Africa [66]. Given
that isolation is known to be an effective public health
control measure, some may view the Cuban approach as
a success. However, it has been strongly criticized from a
human-rights perspective and many feel that such an
approach would not be feasible in other countries [65].
Screening pregnant women for HIV initially generated
much public discourse and demonstrates the clash
between pragmatic public health and human-rights
approaches. Mother-to-child transmission can be reduced
dramatically when appropriate prevention measures are
taken. Voluntary or anonymous testing of pregnant moth-
ers puts newborns at risk because life-saving and cost-
effective interventions cannot be offered should the
mother refuse consent [67]. On the other hand, manda-
tory testing is seen as violating the mother's rights and
civil liberties. In communities where HIV infection carries
significant social stigma, an HIV diagnosis could lead to
expulsion from society and the family unit. Here, the per-
ceived benefits and rights of women to refuse testing (or
disclosure of test results) are weighed against the risks to
infants being exposed to the virus [68]. Again, models
may have little ability to sway the discussion in this
debate, regardless of their results or the technical compe-
tence with which they are constructed.
Another controversial issue revolves around whether tar-
geting interventions to high risk groups, a classic public
health approach, promotes fear and stigmatization, drives
the epidemic 'underground' and in turn contributes to the
problem [69]. The epidemiologic importance of high-fre-
quency transmitter core groups was initially suggested by
Hethcote and Yorke [70]. Cost-effectiveness of treatment
and prevention programs can be high when programs are
tightly targeted [71,72] to core groups such as commercial
sex workers, injection drug users or men who have sex
with men. When resource availability is low, funds should
be targeted on changing the behaviour of those most
likely to contract and spread the epidemic [73]. Most clas-
sical resource allocation models endorse this approach.
However, sociology approaches do not measure success
solely in terms of costs and effectiveness. Decosas argues
that even public health terminology such as "risk groups"
and "targeting" endorses stigmatization, which is difficult
to undo, and that targeting core groups "once translated
from the depoliticized discourse of epidemiology into the
world of real people, takes on the meaning of controlling
'them' in order to protect 'us'" [74].
Recommendations
Resource allocation practices are subject to the influence
of many social and ethical considerations that are not
considered in purely rational models. While it may be
impractical for models to consider these non-quantitative
aspects, model applicability may be improved if the main
drivers are determined and included in the model as
options. Awareness and flexibility allows modellers to
help the decision-maker assess the impact of several non-
quantitative considerations and determine which are
most important. Addressing social and ethical concerns in
a proactive manner can enhance model acceptability,
while ignoring them is a strong barrier to the adoption of
models.BMC Public Health 2009, 9(Suppl 1):S8 http://www.biomedcentral.com/1471-2458/9/S1/S8
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Funding issues
Funding sources may present additional constraints on
the ability of recipients to focus on their established prior-
ities, on the use of certain interventions, on the ability to
refocus funds from existing programs, and on the ability
to disaggregate intervention-impact information.
There is a definite relationship between a country, locality
or institution's degree of reliance on donor funding and
the extent to which donors can influence resource alloca-
tion decisions. Some donors have fixed priorities and
strict agendas. For example, in 2003 the President's Emer-
gency Plan for AIDS Relief (PEPFAR) committed US$15
Billion to scaling up HIV/AIDS related services in coun-
tries that are most resource constrained. PEPFAR has strict
monitoring and evaluation rules, and funds are generally
not pooled with other donors - presumably so that the
impact of the investment can be evaluated. Other donors,
such as the Global Fund for AIDS, Tuberculosis and
Malaria, are not as restrictive and only loosely define their
priorities. Some donor countries support sector-wide
approaches (SWAPs) and pool resource with other donor
agencies; they often collaborate with health and finance
ministries in recipient countries to generate a resource
allocation plan. Very resource-constrained countries, such
as Malawi, rely heavily on donor funding; they may set
their own priorities and try to solicit funds accordingly but
largely they "settle" for the funds and the programs that
donors are offering. Countries that are less dependent on
donor funding have the power to negotiate for their own
priorities and can be selective and reject funding if the pri-
orities do not match their own.
Some donor agencies or foundations may sift through sci-
entific information and when a particular type of inter-
vention is deemed effective they may broadcast a related
program announcement. Community-based organiza-
tions and HIV/AIDS service providers seeking funds will
adapt their vision, mission and programmatic efforts to
accommodate these program announcements rather than
risk investing in programs that are perhaps less fundable.
Good publicity for an intervention, even without proven
effectiveness, may entice donors to encourage its imple-
mentation. As a result, funding for a particular type of
intervention comes in waves, driving several providers
into that direction, irrespective of original priorities. For
example, the "Abstinence, Be faithful, use a Condom"
(ABC) campaign has gained a lot of popularity, esteem
and funding in recent years, even though abstinence has
not proven to be an effective means of HIV prevention
[75].
Existing funding patterns may exert a strong influence on
any new resource allocation. One common allocation
mechanism consists of using the previous year's expendi-
tures as a starting point. Funding tends to be incremental
and interventions that were previously funded typically
expect renewal of funds [76]. Eliminating or even decreas-
ing funds to a program is often met with great resistance.
Therefore, historical spending patterns are the greatest
predictors of where resources will be allocated.
Finally, improving the allocation of HIV/AIDS resources
requires an understanding of the impact of the current
funding, which proves difficult to measure. For example,
it is hard to discern whether a decline in disease preva-
lence results from a natural peak in the epidemic or from
interventions and control policies. There are also multiple
sources of HIV/AIDS intervention funds, and disaggregat-
ing the confounded effect of several programs is problem-
atic since the interaction of program outcomes cannot be
evaluated outside of controlled study environments. For
example, HIV incidence in San Francisco has rebounded
[77]. It is difficult to assess the extent to which the
rebound is a result of a decrease in social marketing, pre-
vention message fatigue, belief that ARVs reduce transmis-
sion or increase in methamphetamine use. Therefore, it
becomes difficult to determine which interventions
should no longer be funded and which require additional
funds and renewed effort.
Recommendations
Thorough knowledge of potential interventions, as well as
their expected impacts, duration and costs, can alleviate
these funding concerns. If assumptions about these input
variables must be made to enable the resource allocation
model, then references and documentation are essential
to avoid either resistance to change or the propensity to
change too quickly. When setting existing allocations as a
starting point and using models only to allocate addi-
tional funds, the health outcomes gained are relatively
small and the full potential value of resource allocation
models is not recognized by decision-makers. When mod-
els are used to reallocate all resources, any dramatic
change to existing allocations is likely to meet resistance.
However, models can be used to highlight the trade-offs
between these two extreme positions and to find a middle
ground that is acceptable to all stakeholders: the funding
agencies, the recipient, and the service providers [20].
Summary
AIDS policy models can provide important input to the
HIV/AIDS policymaking process [78]. This paper has illus-
trated a range of ways in which the use of HIV/AIDS
resource allocation models can be increased. Our analysis
is less concerned with modelling techniques; rather, we
emphasize the role of modellers in alleviating the barriers
to the adoption of models and increasing the contribution
of formal models to the overall resource allocation proc-
ess.BMC Public Health 2009, 9(Suppl 1):S8 http://www.biomedcentral.com/1471-2458/9/S1/S8
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Our key recommendation for improving the applicability
of HIV/AIDS resource allocation models is to treat model
development as a process that involves all interest groups
and end users in regular meetings. The modellers provide
their technical expertise but also act as educators and facil-
itators for all parties involved. Models require making
potentially hidden assumptions explicit, and they provide
powerful scenario analysis features to explore different
options without risk.
Model development begins with the simplest possible
model and proceeds to create a hierarchy of increasingly
complex models. Each addition of complexity is suggested
by sensitivity analysis and discussed by all interest groups,
including feasibility and data requirement. Data require-
ments and accessibility are, however, not the only disad-
vantages of highly complex models. In many situations,
simpler models provide clearer insights, allow faster sen-
sitivity analysis and are more robust to stochastic varia-
tion.
Such a process-based approach creates a framework in
which all the difficulties addressed in the previous sec-
tions can be addresses effectively and efficiently. Through
continuous interaction with all groups, the modellers
understand the environment in which users and decision-
makers are operating. This includes knowledge of the
stakeholders so that the vision on key issues and require-
ments, as well as potential buy-in, can be solicited from
each group. Early consultation may also alleviate some
concerns of those who will be asked to implement the
model results by addressing issues such as social and eth-
ical considerations, data sources and uncertainty, and
stakeholder perspectives at the outset. While the require-
ment for the modellers to fully understand the context of
a decision is not a novel recommendation, it bears repeat-
ing since it remains a demonstrable problem. Formal
decision support models for HIV/AIDS resource alloca-
tion are required, but they should be contextualized and
sensitive to societal concerns and decision-makers' reali-
ties. In parallel, decision-makers need to be willing to
learn about the powers and limitations of models, in
order to avoid abuse of models and their recommenda-
tions.
Some modellers may believe that their models should be
built to reflect "proper" decision methodology and that
current decision processes are flawed. Their aim is to
change governmental and societal approaches to deci-
sion-making, moving it towards a more rational and/or
utilitarian approach. While this vision is vital to foster
growth and development, their model may prove difficult
to implement in the current decision context. Therefore,
modellers should assess how removed their models are
from the current reality and balance their choice of an
ideal vision with that of a practical tool for implementa-
tion.
Models cannot - and arguably should not - capture all of
the qualitative and quantitative intricacies that surround a
decision process. Models cannot be expected to dictate
resource allocation; rather, their results should be used to
support the process and guide discussion and policy
debates. The ability to conduct "what-if" analyses using
models can help decision-makers understand the extent
of the trade-offs resulting from their non-quantifiable
considerations. In order for decision-makers to under-
stand and accept the trade-offs that their decisions incur,
they must be comfortable with - and have confidence in -
the model.
Resource allocation models provide valuable guidance to
the allocation of funds. Knowledge transfer is a prime
issue - how to move the expertise and insights from the
academic realm into that of policymaking and resource
allocation. A first step may be to convince the policymak-
ers of the usefulness of these models by helping them
solve current problems. The desire to increase the impact
of HIV/AIDS funds and to improve global health out-
comes should provide the necessary impetus for model-
lers to enhance the applicability of their models.
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